144 related articles for article (PubMed ID: 16886606)
21. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
22. Regulation of alternative splicing of CD44 in cancer.
Prochazka L; Tesarik R; Turanek J
Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
[TBL] [Abstract][Full Text] [Related]
23. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
25. Trans-acting factors regulate the expression of CD44 splice variants.
Konig H; Moll J; Ponta H; Herrlich P
EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
[TBL] [Abstract][Full Text] [Related]
26. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
Zeilstra J; Joosten SP; van Andel H; Tolg C; Berns A; Snoek M; van de Wetering M; Spaargaren M; Clevers H; Pals ST
Oncogene; 2014 Jan; 33(5):665-70. PubMed ID: 23318432
[TBL] [Abstract][Full Text] [Related]
27. CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE-cadherin junction on metastatic melanoma cells.
Zhang P; Fu C; Bai H; Song E; Dong C; Song Y
FEBS Lett; 2014 Dec; 588(24):4573-82. PubMed ID: 25447529
[TBL] [Abstract][Full Text] [Related]
28. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
29. Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.
Yang K; Tang Y; Iczkowski KA
Am J Transl Res; 2010 Jan; 2(1):88-94. PubMed ID: 20182585
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
31. CD44 expression in astrocytic tumors.
Ylagan LR; Quinn B
Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
[TBL] [Abstract][Full Text] [Related]
32. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
[TBL] [Abstract][Full Text] [Related]
33. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
[TBL] [Abstract][Full Text] [Related]
34. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.
Hanley WD; Napier SL; Burdick MM; Schnaar RL; Sackstein R; Konstantopoulos K
FASEB J; 2006 Feb; 20(2):337-9. PubMed ID: 16352650
[TBL] [Abstract][Full Text] [Related]
35. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
[TBL] [Abstract][Full Text] [Related]
36. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
[TBL] [Abstract][Full Text] [Related]
37. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
Kasper M; Günthert U; Dall P; Kayser K; Schuh D; Haroske G; Müller M
Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
[TBL] [Abstract][Full Text] [Related]
38. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
39. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
40. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
Levesque MC; Haynes BF
J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
